| hypotonic response | GO:0006971 | 3 | 0.998 | |
| circulatory system process | GO:0003013 | 197 | 0.881 | Mouse |
| response to osmotic stress | GO:0006970 | 21 | 0.870 | |
| cation transport | GO:0006812 | 399 | 0.834 | Human |
| neuronal action potential | GO:0019228 | 54 | 0.646 | |
| inorganic cation transmembrane transport | GO:0098662 | 207 | 0.640 | |
| transmission of nerve impulse | GO:0019226 | 76 | 0.629 | |
| cation transmembrane transport | GO:0098655 | 266 | 0.621 | |
| inorganic ion transmembrane transport | GO:0098660 | 234 | 0.530 | Human |
| ion transmembrane transport | GO:0034220 | 361 | 0.520 | Human |
| regulation of blood volume by renal aldosterone | GO:0002017 | 1 | 0.433 | |
| renal system process | GO:0003014 | 48 | 0.432 | Human |
| establishment of blood nerve barrier | GO:0008065 | 3 | 0.429 | |
| inorganic anion transmembrane transport | GO:0098661 | 29 | 0.405 | Human |
| cellular response to osmotic stress | GO:0071470 | 7 | 0.404 | |
| regulation of membrane potential | GO:0042391 | 192 | 0.403 | |
| multicellular organismal signaling | GO:0035637 | 91 | 0.391 | |
| transmembrane transport | GO:0055085 | 412 | 0.388 | Human |
| fat soluble vitamin catabolic process | GO:0042363 | 1 | 0.374 | |
| response to organonitrogen compound | GO:0010243 | 246 | 0.356 | |
| skin development | GO:0043588 | 220 | 0.324 | |
| retinoic acid metabolic process | GO:0042573 | 12 | 0.310 | |
| regulation of metal ion transport | GO:0010959 | 106 | 0.301 | |
| regulation of hormone levels | GO:0010817 | 211 | 0.294 | |
| regulation of blood pressure | GO:0008217 | 93 | 0.272 | Mouse |
| blood circulation | GO:0008015 | 195 | 0.270 | Mouse |
| divalent inorganic cation transport | GO:0072511 | 178 | 0.246 | |
| chloride transmembrane transport | GO:1902476 | 24 | 0.237 | Human |
| anion transmembrane transport | GO:0098656 | 71 | 0.231 | Human |
| potassium ion transmembrane transport | GO:0071805 | 43 | 0.228 | |
| response to peptide hormone | GO:0043434 | 127 | 0.218 | |
| nephron epithelium morphogenesis | GO:0072088 | 68 | 0.215 | Human |
| regulation of ion transmembrane transport | GO:0034765 | 119 | 0.213 | |
| regulation of ion transport | GO:0043269 | 215 | 0.210 | |
| positive regulation of systemic arterial blood pressure | GO:0003084 | 9 | 0.209 | Mouse |
| positive regulation of potassium ion transport | GO:0043268 | 3 | 0.205 | |
| cellular hypotonic response | GO:0071476 | 3 | 0.203 | |
| nephron tubule morphogenesis | GO:0072078 | 68 | 0.201 | Human |
| divalent metal ion transport | GO:0070838 | 172 | 0.194 | |
| action potential | GO:0001508 | 78 | 0.192 | |
| response to insulin | GO:0032868 | 100 | 0.188 | |
| excretion | GO:0007588 | 22 | 0.179 | |
| physiological cardiac muscle hypertrophy | GO:0003301 | 3 | 0.172 | |
| regulation of systemic arterial blood pressure | GO:0003073 | 61 | 0.169 | Mouse |
| regulation of transmembrane transport | GO:0034762 | 128 | 0.166 | |
| multi multicellular organism process | GO:0044706 | 109 | 0.164 | Worm |
| negative regulation of protein metabolic process | GO:0051248 | 282 | 0.162 | |
| regulation of body fluid levels | GO:0050878 | 162 | 0.161 | |
| response to peptide | GO:1901652 | 136 | 0.154 | |
| renal system development | GO:0072001 | 225 | 0.148 | Human |
| nephron tubule development | GO:0072080 | 84 | 0.145 | Human |
| regulation of ion homeostasis | GO:2000021 | 64 | 0.143 | |
| cell cell junction organization | GO:0045216 | 72 | 0.142 | |
| peptidyl threonine modification | GO:0018210 | 31 | 0.142 | |
| sensory perception | GO:0007600 | 245 | 0.138 | |
| urogenital system development | GO:0001655 | 261 | 0.135 | Human |
| metal ion homeostasis | GO:0055065 | 189 | 0.135 | |
| cellular ketone metabolic process | GO:0042180 | 84 | 0.130 | |
| regulation of systemic arterial blood pressure mediated by a chemical signal | GO:0003044 | 33 | 0.130 | |
| potassium ion transport | GO:0006813 | 52 | 0.126 | |
| regulation of potassium ion transmembrane transporter activity | GO:1901016 | 7 | 0.125 | |
| calcium ion transport | GO:0006816 | 159 | 0.125 | |
| cation homeostasis | GO:0055080 | 212 | 0.124 | |
| midgut development | GO:0007494 | 4 | 0.119 | |
| regulation of organ morphogenesis | GO:2000027 | 144 | 0.113 | |
| hormone metabolic process | GO:0042445 | 86 | 0.112 | |
| carboxylic acid biosynthetic process | GO:0046394 | 86 | 0.111 | |
| lipid biosynthetic process | GO:0008610 | 179 | 0.111 | |
| peptidyl amino acid modification | GO:0018193 | 336 | 0.110 | |
| endothelial cell differentiation | GO:0045446 | 41 | 0.109 | |
| ensheathment of neurons | GO:0007272 | 76 | 0.109 | |
| axon ensheathment | GO:0008366 | 76 | 0.108 | |
| developmental growth involved in morphogenesis | GO:0060560 | 138 | 0.108 | |
| small molecule biosynthetic process | GO:0044283 | 132 | 0.107 | |
| glucocorticoid metabolic process | GO:0008211 | 9 | 0.103 | |
| branching morphogenesis of an epithelial tube | GO:0048754 | 159 | 0.102 | |
| endothelial cell development | GO:0001885 | 20 | 0.101 | |
| positive regulation of cellular amino acid metabolic process | GO:0045764 | 3 | 0.101 | |
| negative regulation of cellular protein metabolic process | GO:0032269 | 247 | 0.098 | |
| response to metal ion | GO:0010038 | 47 | 0.091 | |
| epithelial tube morphogenesis | GO:0060562 | 303 | 0.090 | Human |
| muscle system process | GO:0003012 | 141 | 0.088 | |
| response to nutrient levels | GO:0031667 | 109 | 0.087 | |
| axonogenesis | GO:0007409 | 274 | 0.086 | Fly |
| peptidyl serine phosphorylation | GO:0018105 | 74 | 0.086 | |
| renal system process involved in regulation of blood volume | GO:0001977 | 4 | 0.085 | |
| fat soluble vitamin biosynthetic process | GO:0042362 | 4 | 0.085 | |
| response to organic cyclic compound | GO:0014070 | 198 | 0.084 | |
| actin cytoskeleton organization | GO:0030036 | 220 | 0.082 | |
| alcohol metabolic process | GO:0006066 | 116 | 0.082 | |
| amine metabolic process | GO:0009308 | 45 | 0.081 | |
| sensory perception of mechanical stimulus | GO:0050954 | 107 | 0.080 | |
| epithelial cell development | GO:0002064 | 159 | 0.080 | |
| cellular response to peptide | GO:1901653 | 92 | 0.078 | |
| regulation of secretion | GO:0051046 | 274 | 0.077 | |
| nephron morphogenesis | GO:0072028 | 69 | 0.077 | Human |
| gonad development | GO:0008406 | 141 | 0.076 | |
| peptidyl serine modification | GO:0018209 | 83 | 0.075 | |
| negative regulation of molecular function | GO:0044092 | 258 | 0.074 | |
| cellular response to organonitrogen compound | GO:0071417 | 145 | 0.074 | |
| multicellular organismal water homeostasis | GO:0050891 | 23 | 0.074 | |
| cell adhesion | GO:0007155 | 329 | 0.074 | |
| cellular potassium ion transport | GO:0071804 | 43 | 0.074 | |
| regulation of homeostatic process | GO:0032844 | 182 | 0.073 | |
| muscle contraction | GO:0006936 | 101 | 0.071 | |
| regulation of blood circulation | GO:1903522 | 93 | 0.070 | |
| cellular amino acid metabolic process | GO:0006520 | 103 | 0.069 | |
| cellular response to peptide hormone stimulus | GO:0071375 | 92 | 0.069 | |
| retinoid metabolic process | GO:0001523 | 24 | 0.068 | |
| regulation of cellular amine metabolic process | GO:0033238 | 20 | 0.068 | |
| monovalent inorganic cation homeostasis | GO:0055067 | 33 | 0.068 | |
| regulation of inflammatory response | GO:0050727 | 147 | 0.067 | |
| regulation of potassium ion transmembrane transport | GO:1901379 | 11 | 0.065 | |
| response to hypoxia | GO:0001666 | 58 | 0.063 | |
| peptidyl threonine phosphorylation | GO:0018107 | 31 | 0.063 | |
| response to drug | GO:0042493 | 75 | 0.063 | |
| establishment of skin barrier | GO:0061436 | 14 | 0.063 | |
| sensory perception of chemical stimulus | GO:0007606 | 51 | 0.062 | |
| regulation of cell growth | GO:0001558 | 91 | 0.061 | |
| nucleoside phosphate metabolic process | GO:0006753 | 338 | 0.061 | |
| synaptic transmission | GO:0007268 | 329 | 0.060 | |
| muscle cell development | GO:0055001 | 133 | 0.060 | |
| organic cyclic compound catabolic process | GO:1901361 | 295 | 0.060 | |
| steroid metabolic process | GO:0008202 | 119 | 0.059 | |
| regulation of ion transmembrane transporter activity | GO:0032412 | 54 | 0.059 | |
| nucleobase containing small molecule metabolic process | GO:0055086 | 352 | 0.059 | |
| positive regulation of ion transport | GO:0043270 | 65 | 0.058 | |
| organonitrogen compound catabolic process | GO:1901565 | 264 | 0.058 | |
| kidney development | GO:0001822 | 213 | 0.057 | Human |
| sodium ion transmembrane transport | GO:0035725 | 49 | 0.057 | |
| cell growth involved in cardiac muscle cell development | GO:0061049 | 3 | 0.056 | |
| regulation of systemic arterial blood pressure by hormone | GO:0001990 | 25 | 0.056 | |
| muscle cell differentiation | GO:0042692 | 261 | 0.056 | |
| ribose phosphate metabolic process | GO:0019693 | 291 | 0.055 | |
| ras protein signal transduction | GO:0007265 | 77 | 0.055 | |
| purine containing compound metabolic process | GO:0072521 | 311 | 0.054 | |
| organic hydroxy compound metabolic process | GO:1901615 | 203 | 0.054 | |
| purine nucleotide metabolic process | GO:0006163 | 302 | 0.054 | |
| detection of chemical stimulus involved in sensory perception of pain | GO:0050968 | 3 | 0.054 | |
| cellular amine metabolic process | GO:0044106 | 44 | 0.053 | |
| male gamete generation | GO:0048232 | 285 | 0.053 | |
| cellular alcohol biosynthetic process | GO:0044108 | 3 | 0.053 | |
| negative regulation of male mating behavior | GO:1902436 | 1 | 0.053 | |
| nephron development | GO:0072006 | 109 | 0.053 | Human |
| neuron projection guidance | GO:0097485 | 141 | 0.052 | Fly |
| sodium ion homeostasis | GO:0055078 | 7 | 0.051 | |
| response to extracellular stimulus | GO:0009991 | 127 | 0.051 | |
| guanosine containing compound catabolic process | GO:1901069 | 144 | 0.051 | |
| carbohydrate derivative catabolic process | GO:1901136 | 231 | 0.051 | |
| locomotory behavior | GO:0007626 | 195 | 0.050 | |
| inflammatory response | GO:0006954 | 244 | 0.049 | |
| response to oxygen levels | GO:0070482 | 62 | 0.048 | |
| negative regulation of potassium ion transmembrane transporter activity | GO:1901017 | 3 | 0.048 | |
| morphogenesis of a branching structure | GO:0001763 | 203 | 0.047 | |
| organic hydroxy compound transport | GO:0015850 | 93 | 0.046 | |
| development of primary sexual characteristics | GO:0045137 | 143 | 0.046 | |
| renal sodium excretion | GO:0035812 | 3 | 0.046 | |
| ribonucleoside catabolic process | GO:0042454 | 206 | 0.046 | |
| cellular alcohol metabolic process | GO:0044107 | 3 | 0.046 | |
| regulation of cellular amino acid metabolic process | GO:0006521 | 5 | 0.045 | |
| feeding behavior | GO:0007631 | 62 | 0.045 | |
| spermatogenesis | GO:0007283 | 284 | 0.045 | |
| trachea cartilage morphogenesis | GO:0060535 | 4 | 0.044 | |
| 9 cis retinoic acid metabolic process | GO:0042905 | 5 | 0.044 | |
| positive regulation of cellular amine metabolic process | GO:0033240 | 5 | 0.044 | |
| developmental maturation | GO:0021700 | 193 | 0.043 | |
| ribonucleoside metabolic process | GO:0009119 | 245 | 0.042 | |
| intracellular protein transport | GO:0006886 | 204 | 0.042 | |
| myotube differentiation | GO:0014902 | 105 | 0.042 | |
| endocrine process | GO:0050886 | 39 | 0.042 | |
| embryonic epithelial tube formation | GO:0001838 | 130 | 0.042 | |
| terpenoid biosynthetic process | GO:0016114 | 7 | 0.042 | |
| peptide secretion | GO:0002790 | 114 | 0.042 | |
| regulation of purine nucleotide metabolic process | GO:1900542 | 169 | 0.042 | |
| cell junction assembly | GO:0034329 | 52 | 0.041 | |
| purine ribonucleoside metabolic process | GO:0046128 | 241 | 0.041 | |
| negative regulation of protein modification process | GO:0031400 | 163 | 0.041 | |
| inorganic anion transport | GO:0015698 | 43 | 0.040 | |
| striated muscle tissue development | GO:0014706 | 293 | 0.040 | |
| wound healing | GO:0042060 | 157 | 0.040 | |
| transmembrane receptor protein serine threonine kinase signaling pathway | GO:0007178 | 194 | 0.039 | |
| potassium ion homeostasis | GO:0055075 | 4 | 0.039 | |
| apoptotic signaling pathway | GO:0097190 | 306 | 0.039 | |
| cytokine production | GO:0001816 | 319 | 0.039 | |
| positive regulation of protein modification process | GO:0031401 | 299 | 0.038 | |
| regulation of potassium ion transport | GO:0043266 | 16 | 0.038 | |
| purine ribonucleotide metabolic process | GO:0009150 | 290 | 0.038 | |
| mesonephric tubule morphogenesis | GO:0072171 | 63 | 0.038 | |
| kidney epithelium development | GO:0072073 | 121 | 0.038 | Human |
| cellular homeostasis | GO:0019725 | 240 | 0.038 | |
| chloride transport | GO:0006821 | 32 | 0.038 | |
| renal tubule development | GO:0061326 | 87 | 0.038 | Human |
| cellular response to abiotic stimulus | GO:0071214 | 56 | 0.037 | |
| purine nucleoside triphosphate metabolic process | GO:0009144 | 226 | 0.037 | |
| positive regulation of nervous system development | GO:0051962 | 221 | 0.037 | |
| response to inorganic substance | GO:0010035 | 96 | 0.037 | |
| mating | GO:0007618 | 27 | 0.037 | |
| cell growth | GO:0016049 | 130 | 0.036 | |
| gtp metabolic process | GO:0046039 | 144 | 0.036 | |
| nucleotide metabolic process | GO:0009117 | 332 | 0.036 | |
| cell cell junction assembly | GO:0007043 | 27 | 0.036 | |
| regulation of cellular ketone metabolic process | GO:0010565 | 66 | 0.036 | |
| metanephric nephron development | GO:0072210 | 34 | 0.035 | |
| cellular divalent inorganic cation homeostasis | GO:0072503 | 127 | 0.035 | |
| regulation of protein localization | GO:0032880 | 231 | 0.035 | |
| monocarboxylic acid metabolic process | GO:0032787 | 191 | 0.035 | |
| divalent inorganic cation homeostasis | GO:0072507 | 138 | 0.035 | |
| renal tubule morphogenesis | GO:0061333 | 72 | 0.034 | Human |
| c21 steroid hormone biosynthetic process | GO:0006700 | 3 | 0.034 | |
| nucleoside phosphate catabolic process | GO:1901292 | 222 | 0.034 | |
| purine ribonucleoside catabolic process | GO:0046130 | 205 | 0.034 | |
| morphogenesis of an epithelial sheet | GO:0002011 | 27 | 0.034 | |
| hormone secretion | GO:0046879 | 128 | 0.034 | |
| positive regulation of purine nucleotide metabolic process | GO:1900544 | 114 | 0.034 | |
| positive regulation of nucleoside metabolic process | GO:0045979 | 91 | 0.034 | |
| single organismal cell cell adhesion | GO:0016337 | 131 | 0.034 | |
| establishment of planar polarity involved in neural tube closure | GO:0090177 | 15 | 0.033 | |
| protein secretion | GO:0009306 | 111 | 0.033 | |
| carbohydrate derivative biosynthetic process | GO:1901137 | 183 | 0.033 | |
| skeletal muscle satellite cell maintenance involved in skeletal muscle regeneration | GO:0014834 | 3 | 0.033 | |
| regulation of renal sodium excretion | GO:0035813 | 3 | 0.033 | |
| calcium ion homeostasis | GO:0055074 | 127 | 0.033 | |
| positive regulation of nucleotide metabolic process | GO:0045981 | 114 | 0.033 | |
| glycosyl compound metabolic process | GO:1901657 | 246 | 0.033 | |
| organic hydroxy compound biosynthetic process | GO:1901617 | 77 | 0.032 | |
| cell substrate adhesion | GO:0031589 | 130 | 0.032 | |
| protein targeting | GO:0006605 | 143 | 0.032 | |
| nitrogen compound transport | GO:0071705 | 271 | 0.032 | |
| placenta development | GO:0001890 | 140 | 0.031 | |
| regulation of cell morphogenesis involved in differentiation | GO:0010769 | 151 | 0.031 | |
| nucleoside metabolic process | GO:0009116 | 246 | 0.031 | |
| cellular response to insulin stimulus | GO:0032869 | 78 | 0.031 | |
| hair cycle | GO:0042633 | 90 | 0.031 | |
| positive regulation of gtpase activity | GO:0043547 | 85 | 0.031 | |
| cellular ion homeostasis | GO:0006873 | 165 | 0.030 | |
| regulation of activation of jak2 kinase activity | GO:0010534 | 1 | 0.030 | |
| regulation of gtp catabolic process | GO:0033124 | 113 | 0.030 | |
| regulation of nucleoside metabolic process | GO:0009118 | 130 | 0.030 | |
| vitamin d3 metabolic process | GO:0070640 | 3 | 0.030 | |
| negative regulation of ion transport | GO:0043271 | 28 | 0.030 | |
| vitamin catabolic process | GO:0009111 | 1 | 0.030 | |
| sodium ion transport | GO:0006814 | 73 | 0.030 | Human |
| multicellular organismal response to stress | GO:0033555 | 62 | 0.030 | |
| small gtpase mediated signal transduction | GO:0007264 | 97 | 0.030 | |
| central nervous system neuron differentiation | GO:0021953 | 162 | 0.030 | |
| mapk cascade | GO:0000165 | 281 | 0.029 | |
| regulation of nucleotide metabolic process | GO:0006140 | 169 | 0.029 | |
| peptide hormone secretion | GO:0030072 | 109 | 0.028 | |
| 9 cis retinoic acid biosynthetic process | GO:0042904 | 5 | 0.028 | |
| organic acid biosynthetic process | GO:0016053 | 86 | 0.028 | |
| epithelial tube formation | GO:0072175 | 130 | 0.028 | |
| nephric duct formation | GO:0072179 | 4 | 0.028 | |
| reactive nitrogen species metabolic process | GO:2001057 | 0 | 0.027 | |
| secondary alcohol metabolic process | GO:1902652 | 3 | 0.027 | |
| olfactory bulb axon guidance | GO:0071678 | 1 | 0.027 | |
| cellular response to inorganic substance | GO:0071241 | 37 | 0.027 | |
| regulation of protein kinase activity | GO:0045859 | 232 | 0.027 | |
| regulation of defense response | GO:0031347 | 233 | 0.027 | |
| regulation of striated muscle cell differentiation | GO:0051153 | 81 | 0.027 | |
| cellular response to external stimulus | GO:0071496 | 88 | 0.027 | |
| diterpenoid biosynthetic process | GO:0016102 | 7 | 0.027 | |
| negative regulation of phosphorylation | GO:0042326 | 166 | 0.027 | |
| calcium independent cell cell adhesion via plasma membrane cell adhesion molecules | GO:0016338 | 4 | 0.027 | |
| organonitrogen compound biosynthetic process | GO:1901566 | 192 | 0.026 | |
| retinoic acid biosynthetic process | GO:0002138 | 7 | 0.026 | |
| aromatic compound catabolic process | GO:0019439 | 286 | 0.026 | |
| planar cell polarity pathway involved in outflow tract morphogenesis | GO:0061347 | 2 | 0.026 | |
| rho protein signal transduction | GO:0007266 | 32 | 0.026 | |
| purine ribonucleoside triphosphate catabolic process | GO:0009207 | 199 | 0.026 | |
| regulation of ras gtpase activity | GO:0032318 | 88 | 0.026 | |
| positive regulation of protein phosphorylation | GO:0001934 | 242 | 0.026 | |
| cellular chemical homeostasis | GO:0055082 | 215 | 0.026 | |
| positive regulation of neuron differentiation | GO:0045666 | 141 | 0.026 | |
| mechanosensory behavior | GO:0007638 | 6 | 0.026 | |
| isoprenoid biosynthetic process | GO:0008299 | 9 | 0.025 | |
| purine nucleotide catabolic process | GO:0006195 | 211 | 0.025 | |
| positive regulation of transferase activity | GO:0051347 | 167 | 0.025 | |
| guanosine containing compound metabolic process | GO:1901068 | 144 | 0.025 | |
| purine nucleoside triphosphate catabolic process | GO:0009146 | 203 | 0.025 | |
| oocyte axis specification | GO:0007309 | 2 | 0.025 | |
| positive regulation of hydrolase activity | GO:0051345 | 148 | 0.025 | |
| development of primary female sexual characteristics | GO:0046545 | 73 | 0.025 | |
| monocarboxylic acid biosynthetic process | GO:0072330 | 61 | 0.025 | |
| actin filament organization | GO:0007015 | 113 | 0.025 | |
| mammary gland epithelium development | GO:0061180 | 65 | 0.025 | |
| vitamin d biosynthetic process | GO:0042368 | 3 | 0.024 | |
| organ growth | GO:0035265 | 117 | 0.024 | |
| regulation of cytoskeleton organization | GO:0051493 | 122 | 0.024 | |
| morphogenesis of a branching epithelium | GO:0061138 | 193 | 0.024 | |
| regulation of system process | GO:0044057 | 200 | 0.024 | |
| negative regulation of phosphorus metabolic process | GO:0010563 | 184 | 0.024 | |
| pharynx development | GO:0060465 | 1 | 0.024 | |
| angiogenesis | GO:0001525 | 201 | 0.024 | |
| oxidation reduction process | GO:0055114 | 342 | 0.024 | |
| g protein coupled receptor signaling pathway | GO:0007186 | 243 | 0.024 | |
| regulation of kinase activity | GO:0043549 | 249 | 0.024 | |
| amide transport | GO:0042886 | 138 | 0.024 | |
| osmosensory signaling pathway | GO:0007231 | 1 | 0.024 | |
| response to decreased oxygen levels | GO:0036293 | 59 | 0.024 | |
| ribonucleoside triphosphate metabolic process | GO:0009199 | 220 | 0.023 | |
| regulation of mapk cascade | GO:0043408 | 248 | 0.023 | |
| positive regulation of protein transport | GO:0051222 | 93 | 0.023 | |
| cellular response to cytokine stimulus | GO:0071345 | 189 | 0.023 | |
| branching involved in ureteric bud morphogenesis | GO:0001658 | 56 | 0.023 | |
| smooth muscle contraction | GO:0006939 | 44 | 0.023 | |
| multicellular organismal homeostasis | GO:0048871 | 164 | 0.023 | |
| embryonic appendage morphogenesis | GO:0035113 | 126 | 0.023 | |
| response to temperature stimulus | GO:0009266 | 55 | 0.023 | |
| regulation of cellular catabolic process | GO:0031329 | 242 | 0.023 | |
| cellular response to extracellular stimulus | GO:0031668 | 81 | 0.023 | |
| mesenchyme development | GO:0060485 | 152 | 0.023 | |
| nuclear division | GO:0000280 | 158 | 0.023 | |
| positive regulation of extracellular matrix organization | GO:1903055 | 4 | 0.023 | |
| cytoplasmic transport | GO:0016482 | 234 | 0.023 | |
| negative regulation of potassium ion transmembrane transport | GO:1901380 | 4 | 0.023 | |
| physiological muscle hypertrophy | GO:0003298 | 3 | 0.023 | |
| regulation of transporter activity | GO:0032409 | 57 | 0.023 | |
| muscle tissue development | GO:0060537 | 308 | 0.023 | |
| regulation of cell activation | GO:0050865 | 289 | 0.023 | |
| glycosyl compound catabolic process | GO:1901658 | 206 | 0.023 | |
| cellular lipid metabolic process | GO:0044255 | 323 | 0.023 | |
| organophosphate biosynthetic process | GO:0090407 | 122 | 0.022 | |
| diterpenoid metabolic process | GO:0016101 | 24 | 0.022 | |
| negative regulation of phosphate metabolic process | GO:0045936 | 184 | 0.022 | |
| positive regulation of gtp catabolic process | GO:0033126 | 85 | 0.022 | |
| canonical wnt signaling pathway involved in regulation of cell proliferation | GO:0044340 | 3 | 0.022 | |
| ribonucleotide catabolic process | GO:0009261 | 208 | 0.022 | |
| transmembrane receptor protein tyrosine kinase signaling pathway | GO:0007169 | 247 | 0.022 | |
| regulation of superoxide anion generation | GO:0032928 | 4 | 0.022 | |
| regulation of transferase activity | GO:0051338 | 263 | 0.022 | |
| mesonephric epithelium development | GO:0072163 | 94 | 0.022 | |
| biological phase | GO:0044848 | 20 | 0.022 | |
| extracellular matrix organization | GO:0030198 | 147 | 0.021 | |
| axis elongation involved in somitogenesis | GO:0090245 | 4 | 0.021 | |
| activation of janus kinase activity | GO:0042976 | 2 | 0.021 | |
| nucleoside catabolic process | GO:0009164 | 206 | 0.021 | |
| cellular nitrogen compound catabolic process | GO:0044270 | 280 | 0.021 | |
| positive regulation of secretion | GO:0051047 | 130 | 0.021 | |
| stem cell proliferation | GO:0072089 | 117 | 0.021 | |
| regulation of hydrolase activity | GO:0051336 | 246 | 0.021 | |
| cellular component assembly involved in morphogenesis | GO:0010927 | 139 | 0.021 | |
| renal system process involved in regulation of systemic arterial blood pressure | GO:0003071 | 15 | 0.021 | |
| mitotic chromosome condensation | GO:0007076 | 1 | 0.020 | |
| nucleoside triphosphate metabolic process | GO:0009141 | 230 | 0.020 | |
| purine nucleoside catabolic process | GO:0006152 | 205 | 0.020 | |
| planar cell polarity pathway involved in pericardium morphogenesis | GO:0061354 | 2 | 0.020 | |
| regulation of cell adhesion | GO:0030155 | 154 | 0.020 | |
| norepinephrine transport | GO:0015874 | 2 | 0.020 | |
| hemostasis | GO:0007599 | 78 | 0.020 | |
| stress activated mapk cascade | GO:0051403 | 80 | 0.020 | |
| peptide transport | GO:0015833 | 133 | 0.020 | |
| smooth muscle contraction involved in micturition | GO:0060083 | 3 | 0.020 | |
| protein localization to organelle | GO:0033365 | 185 | 0.020 | |
| organic anion transport | GO:0015711 | 137 | 0.020 | |
| regulation of synaptic activity | GO:0060025 | 1 | 0.020 | |
| positive regulation of cellular catabolic process | GO:0031331 | 148 | 0.020 | |
| camera type eye development | GO:0043010 | 266 | 0.020 | |
| female sex differentiation | GO:0046660 | 84 | 0.020 | |
| regulation of epithelial cell proliferation | GO:0050678 | 141 | 0.019 | |
| response to amino acid | GO:0043200 | 37 | 0.019 | |
| positive regulation of secretion by cell | GO:1903532 | 114 | 0.019 | |
| response to acid chemical | GO:0001101 | 111 | 0.019 | |
| skeletal system morphogenesis | GO:0048705 | 203 | 0.019 | |
| organelle fission | GO:0048285 | 170 | 0.019 | |
| lipid transport | GO:0006869 | 98 | 0.019 | |
| positive regulation of protein kinase activity | GO:0045860 | 144 | 0.019 | |
| non canonical wnt signaling pathway involved in heart development | GO:0061341 | 3 | 0.019 | |
| regulation of protein serine threonine kinase activity | GO:0071900 | 157 | 0.019 | |
| heart growth | GO:0060419 | 45 | 0.019 | |
| protein modification by small protein conjugation or removal | GO:0070647 | 207 | 0.019 | |
| purine nucleoside metabolic process | GO:0042278 | 241 | 0.019 | |
| insulin receptor signaling pathway | GO:0008286 | 49 | 0.019 | |
| establishment of protein localization to organelle | GO:0072594 | 118 | 0.019 | |
| regulation of peptide secretion | GO:0002791 | 77 | 0.019 | |
| cardiac right atrium morphogenesis | GO:0003213 | 3 | 0.019 | |
| response to steroid hormone | GO:0048545 | 56 | 0.019 | |
| development of primary male sexual characteristics | GO:0046546 | 88 | 0.019 | |
| cellular response to lipid | GO:0071396 | 145 | 0.019 | |
| chemotaxis | GO:0006935 | 247 | 0.018 | Fly |
| nucleotide catabolic process | GO:0009166 | 217 | 0.018 | |
| purine ribonucleotide catabolic process | GO:0009154 | 208 | 0.018 | |
| regulation of reactive oxygen species metabolic process | GO:2000377 | 40 | 0.018 | |
| aldosterone metabolic process | GO:0032341 | 2 | 0.018 | |
| hair cycle phase | GO:0044851 | 16 | 0.018 | |
| monoamine transport | GO:0015844 | 33 | 0.018 | |
| mammary gland duct morphogenesis | GO:0060603 | 38 | 0.018 | |
| response to molecule of bacterial origin | GO:0002237 | 143 | 0.018 | |
| heart contraction | GO:0060047 | 93 | 0.018 | |
| response to vitamin d | GO:0033280 | 3 | 0.018 | |
| tertiary branching involved in mammary gland duct morphogenesis | GO:0060748 | 3 | 0.018 | |
| cellular metal ion homeostasis | GO:0006875 | 151 | 0.018 | |
| regulation of establishment of protein localization | GO:0070201 | 181 | 0.018 | |
| multicellular organism growth | GO:0035264 | 161 | 0.018 | |
| nephron tubule formation | GO:0072079 | 20 | 0.018 | |
| central nervous system morphogenesis | GO:0021551 | 2 | 0.018 | |
| wound healing spreading of cells | GO:0044319 | 8 | 0.018 | |
| microtubule based process | GO:0007017 | 236 | 0.018 | |
| skeletal muscle fiber development | GO:0048741 | 58 | 0.018 | |
| regulation of organ growth | GO:0046620 | 61 | 0.018 | |
| peripheral nervous system development | GO:0007422 | 53 | 0.018 | |
| positive regulation of vasodilation | GO:0045909 | 3 | 0.017 | |
| regulation of ossification | GO:0030278 | 112 | 0.017 | |
| cardiac cell development | GO:0055006 | 41 | 0.017 | |
| kidney morphogenesis | GO:0060993 | 83 | 0.017 | Human |
| regulation of actin cytoskeleton organization | GO:0032956 | 84 | 0.017 | |
| regulation of apoptotic signaling pathway | GO:2001233 | 197 | 0.017 | |
| smad protein complex assembly | GO:0007183 | 1 | 0.017 | |
| positive regulation of kinase activity | GO:0033674 | 155 | 0.017 | |
| mitotic cell cycle | GO:0000278 | 195 | 0.017 | |
| positive regulation of reactive oxygen species metabolic process | GO:2000379 | 11 | 0.017 | |
| regulation of mesonephros development | GO:0061217 | 24 | 0.017 | |
| regulation of cell motility | GO:2000145 | 236 | 0.017 | |
| cell cell adhesion | GO:0098609 | 41 | 0.017 | |
| striated muscle cell development | GO:0055002 | 125 | 0.017 | |
| heterocycle catabolic process | GO:0046700 | 280 | 0.017 | |
| positive regulation of peptidyl tyrosine phosphorylation | GO:0050731 | 61 | 0.017 | |
| regulation of stem cell differentiation | GO:2000736 | 50 | 0.017 | |
| regulation of secretion by cell | GO:1903530 | 249 | 0.017 | |
| positive regulation of nucleotide catabolic process | GO:0030813 | 88 | 0.016 | |
| cardiocyte differentiation | GO:0035051 | 87 | 0.016 | |
| lateral line system development | GO:0048925 | 1 | 0.016 | |
| anion transport | GO:0006820 | 177 | 0.016 | |
| negative regulation of potassium ion transport | GO:0043267 | 7 | 0.016 | |
| hematopoietic progenitor cell differentiation | GO:0002244 | 143 | 0.016 | |
| purine ribonucleoside triphosphate metabolic process | GO:0009205 | 220 | 0.016 | |
| defecation | GO:0030421 | 1 | 0.016 | |
| developmental cell growth | GO:0048588 | 84 | 0.016 | |
| regulation of anatomical structure size | GO:0090066 | 178 | 0.016 | |
| cell recognition | GO:0008037 | 83 | 0.016 | |
| urinary tract smooth muscle contraction | GO:0014848 | 6 | 0.016 | |
| ribonucleotide metabolic process | GO:0009259 | 291 | 0.016 | |
| epithelial cell migration | GO:0010631 | 63 | 0.016 | |
| regulation of kidney development | GO:0090183 | 40 | 0.016 | |
| detection of stimulus involved in sensory perception | GO:0050906 | 44 | 0.016 | |
| cell activation involved in immune response | GO:0002263 | 126 | 0.016 | |
| phospholipid metabolic process | GO:0006644 | 87 | 0.016 | |
| negative regulation of cell proliferation | GO:0008285 | 296 | 0.016 | |
| myoblast differentiation involved in skeletal muscle regeneration | GO:0014835 | 3 | 0.016 | |
| regulation of neuronal synaptic plasticity | GO:0048168 | 30 | 0.016 | |
| urinary bladder smooth muscle contraction | GO:0014832 | 5 | 0.016 | |
| activation of nf kappab inducing kinase activity | GO:0007250 | 4 | 0.016 | |
| regulation of myotube differentiation | GO:0010830 | 62 | 0.016 | |
| negative regulation of muscle cell differentiation | GO:0051148 | 33 | 0.016 | |
| anatomical structure maturation | GO:0071695 | 49 | 0.016 | |
| planar cell polarity pathway involved in cardiac right atrium morphogenesis | GO:0061349 | 2 | 0.016 | |
| lipid catabolic process | GO:0016042 | 69 | 0.016 | |
| nucleoside triphosphate catabolic process | GO:0009143 | 205 | 0.016 | |
| regulation of cell cycle process | GO:0010564 | 160 | 0.016 | |
| biomineral tissue development | GO:0031214 | 64 | 0.016 | |
| paraxial mesodermal cell differentiation | GO:0048342 | 2 | 0.015 | |
| myeloid leukocyte differentiation | GO:0002573 | 119 | 0.015 | |
| positive regulation of purine nucleotide catabolic process | GO:0033123 | 88 | 0.015 | |
| regulation of purine nucleotide catabolic process | GO:0033121 | 122 | 0.015 | |
| tissue homeostasis | GO:0001894 | 115 | 0.015 | |
| regulation of peptide transport | GO:0090087 | 91 | 0.015 | |
| organelle assembly | GO:0070925 | 177 | 0.015 | |
| cellular response to hormone stimulus | GO:0032870 | 150 | 0.015 | |
| homeostasis of number of cells | GO:0048872 | 210 | 0.015 | |
| positive regulation of protein serine threonine kinase activity | GO:0071902 | 106 | 0.015 | |
| satellite cell activation involved in skeletal muscle regeneration | GO:0014901 | 3 | 0.015 | |
| regulation of muscle tissue development | GO:1901861 | 97 | 0.015 | |
| regulation of cellular response to stress | GO:0080135 | 159 | 0.015 | |
| cellular calcium ion homeostasis | GO:0006874 | 119 | 0.015 | |
| regulation of cytokine production | GO:0001817 | 266 | 0.015 | |
| planar cell polarity pathway involved in cardiac muscle tissue morphogenesis | GO:0061350 | 2 | 0.015 | |
| regulation of response to wounding | GO:1903034 | 189 | 0.015 | |
| nuclear import | GO:0051170 | 95 | 0.015 | |
| sensory perception of sound | GO:0007605 | 97 | 0.015 | |
| ribonucleoside triphosphate catabolic process | GO:0009203 | 199 | 0.015 | |
| respiratory system development | GO:0060541 | 190 | 0.015 | |
| detection of stimulus | GO:0051606 | 84 | 0.015 | |
| regulation of organelle organization | GO:0033043 | 289 | 0.015 | |
| regulation of activation of janus kinase activity | GO:0010533 | 1 | 0.015 | |
| negative regulation of hormone metabolic process | GO:0032351 | 4 | 0.014 | |
| bone development | GO:0060348 | 120 | 0.014 | |
| limb development | GO:0060173 | 166 | 0.014 | |
| regulation of neurotrophin trk receptor signaling pathway | GO:0051386 | 4 | 0.014 | |
| cellular protein catabolic process | GO:0044257 | 155 | 0.014 | |
| oocyte anterior posterior axis specification | GO:0007314 | 2 | 0.014 | |
| calcitriol biosynthetic process from calciol | GO:0036378 | 3 | 0.014 | |
| epithelial cell proliferation | GO:0050673 | 174 | 0.014 | |
| protein import | GO:0017038 | 101 | 0.014 | |
